Clinical trial
Gene Therapy for Gyrate Atrophy
NCT00001735 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00001735 |
|---|---|
| Title | Gene Therapy for Gyrate Atrophy |
| Official title | Phase I Study in the Safety and Efficacy of Transduced Keratinocytes for Possible Treatment of Gyrate Atrophy |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Gyrate Atrophy |
| Intervention type | Procedure |
| Interventions | Gene therapy |
| Enrollment | 5 |
| Start date | Apr 1, 1998 |
| Completion | Oct 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: